Krystal Biotech KRYS
$308.89 −$6.93 (-2.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $308.85 -0.01%
Open$313.38
Prev close$315.82
Day range$308.22 – $321.27
Volume286.7K
Market cap$9.15B
P/E (TTM)42.0
Dividend yield–
Analyst view
ConsensusBuy
Analysts6
Average target$393.17+27.3% vs. price
- Buy 100%
Low $361.00Now $308.89Avg $393.17High $441.00
Recent rating changes
The last 20 actions on file set price targets from $361.00 to $441.00, averaging $395.72.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 6 Nov 2026 | RBC Capital | BUY | $375.00 |
| 3 Nov 2026 | TD Cowen | BUY | $380.00 |
| 3 Nov 2026 | Citi | BUY | $412.00 |
| 2 Nov 2026 | BofA Securities | BUY | $390.00 |
| 2 Nov 2026 | Citi | BUY | $412.00 |
| 2 Nov 2026 | H.C. Wainwright | BUY | $361.00 |
| 2 Nov 2026 | RBC Capital | BUY | $375.00 |
| 21 Oct 2026 | TD Cowen | BUY | $403.00 |
| 16 Oct 2026 | Citi | BUY | $416.00 |
| 15 Oct 2026 | Citi | BUY | $416.00 |
| 15 Oct 2026 | H.C. Wainwright | BUY | $361.00 |
| 8 Oct 2026 | RBC Capital | BUY | $400.00 |
| 24 Sep 2026 | Goldman Sachs | BUY | $441.00 |
| 21 Sep 2026 | BofA Securities | BUY | $400.00 |
| 14 Aug 2026 | RBC Capital | BUY | $400.00 |
| 11 Aug 2026 | Wolfe Research | HOLD | – |
| 4 Aug 2026 | Citi | BUY | $386.00 |
| 3 Aug 2026 | TD Cowen | BUY | $403.00 |
| 3 Aug 2026 | William Blair | BUY | – |
| 3 Aug 2026 | BofA Securities | BUY | $392.00 |
No comments yet — be the first to weigh in on KRYS.
Sign in to join the discussion.